TELA Bio, Inc. (TELA) Financials

$2.72

south_east
-$0.12 (-4.23%)
Day's range
$2.7
Day's range
$2.88
$60M$60M$40M$40M$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60MEarning201720172018201820192019202020202021202120222022202320230%0%-100%-100%-200%-200%-300%-300%-400%-400%-500%-500%-600%-600%Profit Margin
Profit Margin
Revenue
Earnings

TELA Income statement / Annual

Last year (2023), TELA Bio, Inc.'s total revenue was $58.45 M, an increase of 41.13% from the previous year. In 2023, TELA Bio, Inc.'s net income was -$46.66 M. See TELA Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Operating Revenue $58.45 M $41.42 M $29.46 M $18.21 M $15.45 M $8.27 M $4.25 M
Cost of Revenue $18.34 M $14.37 M $10.65 M $6.98 M $6.17 M $5.33 M $1.71 M
Gross Profit $40.11 M $27.04 M $18.81 M $11.23 M $9.27 M $2.94 M $2.53 M
Gross Profit Ratio 0.69 0.65 0.64 0.62 0.6 0.36 0.6
Research and Development Expenses $9.62 M $8.94 M $6.74 M $4.26 M $4.15 M $4.34 M $5.79 M
General & Administrative Expenses $14.89 M $13.86 M $12.46 M $10.14 M $6.22 M $4.90 M $4.96 M
Selling & Marketing Expenses $59.68 M $43.25 M $29.06 M $22.11 M $18.06 M $13.65 M $8.71 M
Selling, General & Administrative Expenses $74.57 M $57.11 M $41.52 M $32.25 M $24.28 M $18.55 M $13.67 M
Other Expenses $0.00 -$10,000.00 -$228,000.00 $45,000.00 $351,000.00 $70,000.00 $94,000.00
Operating Expenses $84.19 M $66.05 M $48.26 M $36.51 M $28.43 M $22.88 M $19.46 M
Cost And Expenses $102.53 M $80.43 M $58.91 M $43.49 M $34.61 M $28.22 M $21.17 M
Interest Income $0.00 $4.05 M $3.60 M $3.56 M $3.61 M $0.00 $0.00
Interest Expense $5.22 M $4.05 M $3.60 M $3.56 M $3.61 M $1.80 M $4.56 M
Depreciation & Amortization $808,000.00 $1.19 M $535,000.00 $525,000.00 $582,000.00 $1.25 M $761,000.00
EBITDA -$40.63 M -$39.06 M -$29.14 M -$24.71 M -$18.23 M -$18.04 M -$16.02 M
EBITDA Ratio -0.7 -0.94 -1.01 -1.39 -1.22 -2.25 -3.79
Operating Income Ratio -0.75 -0.94 -1 -1.39 -1.24 -2.15 -3.99
Total Other Income/Expenses Net -$2.59 M -$5.29 M -$3.83 M -$3.52 M -$3.26 M -$3.31 M -$4.41 M
Income Before Tax -$46.66 M -$44.30 M -$33.28 M -$28.79 M -$22.43 M -$21.09 M -$21.33 M
Income Before Tax Ratio -0.8 -1.07 -1.13 -1.58 -1.45 -2.55 -5.03
Income Tax Expense $0.00 $41,000.00 $2.83 M $3.08 M $3.38 M -$1.51 M $4.65 M
Net Income -$46.66 M -$44.34 M -$36.11 M -$31.88 M -$25.80 M -$21.09 M -$21.33 M
Net Income Ratio -0.8 -1.07 -1.23 -1.75 -1.67 -2.55 -5.03
EPS -2.04 -2.73 -2.49 -2.46 -2.26 -3.25 -3.29
EPS Diluted -2.04 -2.73 -2.49 -2.46 -2.26 -3.25 -3.29
Weighted Average Shares Out $22.87 M $16.27 M $14.47 M $12.93 M $11.41 M $6.49 M $6.49 M
Weighted Average Shares Out Diluted $22.87 M $16.27 M $14.47 M $12.93 M $11.41 M $6.49 M $6.49 M
Link